In cutaneous melanoma, Li et al [50] demonstrated that BRMS1 expression was significantly decreased in melanoma metastases when compared with primary melanomas, and reduced BRMS1 staining was associated with worse patient survival. The gene discussed is BRMS1; the disease is melanoma.